Appreciate the post! A similar topic came up in a recent DC global health & development discussion
Could another argument for skipping the cash arm be having more resources for other RCTs?
Ideally, we’d study the cash arm and the asset transfer program simultaneously at multiple time periods. But each extra treatment arm and time period costs extra. I imagine one could use the savings for other RCTs instead.
Appreciate the post! A similar topic came up in a recent DC global health & development discussion
Could another argument for skipping the cash arm be having more resources for other RCTs?
Ideally, we’d study the cash arm and the asset transfer program simultaneously at multiple time periods. But each extra treatment arm and time period costs extra. I imagine one could use the savings for other RCTs instead.